Aminoglycoside resistance dynamics and its predictive value for carbapenem resistance in multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae

This publication has 22 references indexed in Scilit:

• Is there evidence on the optimal duration of aminoglycoside therapy in β-lactam/aminoglycoside combination regimens used for the treatment of gram-negative bacterial infections? A systematic review
  International Journal of Antimicrobial Agents, 2024
• Collecting Multi-country Retrospective Antimicrobial Consumption and Use Data: Challenges and Experience
  Clinical Infectious Diseases, 2023
• An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation
  Microbiological Research, 2021
• Aminoglycoside Resistance
  Infectious Disease Clinics of North America, 2020
• Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli
  Journal of Global Antimicrobial Resistance, 2019
• Aminoglycoside Resistance
  Infectious Disease Clinics of North America, 2016
• Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
  MedChemComm, 2015
• Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
  International Journal of Antimicrobial Agents, 2010
• The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
  The Lancet Infectious Diseases, 2009
• Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
  Clinical Infectious Diseases, 2006